The challenge of informed consent for increased risk living donation and transplantation

American Journal of Transplantation

Volumn 11, Issue 12, 2011, Pages 2569-2574

  Gordon, E J ^a   Beauvais, N ^b   Theodoropoulos, N ^a   Hanneman, J ^b   McNatt, G ^b   Penrod, D ^b   Jensen, S ^a   Franklin, J ^a   Sherman, L ^a   Ison, M G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

CDC; ethics; HBV; HCV; HIV; infectious disease transmission; informed consent; living donor; OPTN increased risk; safety

Indexed keywords

ADULT; BENEFICENCE; CASE REPORT; CASE STUDY; CLINICAL EVALUATION; DISEASE TRANSMISSION; FEMALE; GRAFT RECIPIENT; HEALTH INSURANCE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; INFORMED CONSENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MALE HOMOSEXUAL; PATIENT ADVOCACY; PATIENT AUTONOMY; PATIENT DECISION MAKING; PATIENT SAFETY; PERSUASIVE COMMUNICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SELF REPORT; DECISION MAKING; DRUG SAFETY; ETHICS; HUMAN TISSUE; NONHUMAN; NOTE; ORGAN TRANSPLANTATION; PRIVACY; RISK BEHAVIOR; SURGERY;

DECISION MAKING; HUMANS; INFORMED CONSENT; LIVING DONORS; ORGAN TRANSPLANTATION; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT;

EID: 82455212955     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03814.x     Document Type: Review

References (26)

1. Ahn J, Cohen SM,. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2008; 14: 1603-1608.
2. Centers for Disease Control and Prevention. HIV transmitted from a living organ donor - New York City, 2009. Morb Mortal Wkly Rep 2011; 60: 297-301.
3. Centers for Disease Control and Prevention. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR Recomm Wkly Rep 1994; 43(RR-8): 1-17.
4. OPTN. Policy 4.2. Requirements for informed consent regarding risk of transmissible disease. Richmond, VA: United Network for Organ Sharing, 2010.
5. Kucirka L, Namuyinga R, Hanrahan C, Montgomery R, Segev D,. Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant 2009; 9: 629-635.
6. Kucirka L, Alexander C, Namuyinga R, Hanrahan C, Montgomery R, Segev D,. Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs. Am J Transplant 2009; 9 620-628.
7. Reese P, Feldman H, Asch D, et al,. Transplantation of kidneys from donors at increased risk for blood-borne viral infection: Recipient outcomes and patterns of organ use. Am J Transplant 2009; 9: 1-8.
8. Kucirka L, Sarathy H, Govindan P, et al,. Risk of window period HIV infection in high infectious risk donors: Systematic review and meta-analysis. Am J Transplant 2010; 10: 2700-2711.
9. Kucirka L, Sarathy H, Govindan P, et al,. Risk of window period hepatitis-C infection in high infectious risk donors: Systematic review and meta-analysis. Am J Transplant 2011; 11: 1-13.
10. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. Rockville, MD: U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation.
11. Ison M, Nalesnik M,. An update on donor-derived disease transmission in organ transplantation. Am J Transplant 2011; 11: 1123-1130.
12. Wu H, Nishimi R, Page-Lopez C, Kizer K,. Improving patient safety through informed consent for patients with limited health literacy. Washington, DC: National Quality Forum, 2005.
13. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. 42 CFR parts 405, 482, 488, and 498 Medicare program; hospital conditions of participation: Requirements for approval and re-approval of transplant centers to perform organ transplants; final rule. Available at: http://www.cms.hhs.gov/CertificationandComplianc/downloads/Transplantfinal.pdf 2007. Accessed November 23, 2009.
14. Tversky A, Kahneman D,. The framing of decisions and the psychology of choice. Science 1981; 211: 453-458. (Pubitemid 11145313)
15. Nolan M, Walton-Moss B, Taylor L, Dane K,. Living kidney donor decision making: State of the science and directions for future research. Prog Transplant 2004; 14: 201-209. (Pubitemid 39202648)
16. Papachristou C, Walter M, Dietrich K, et al,. Motivation for living-donor liver transplantation from the donor's perspective: An in-depth qualitative research study. Transplantation 2004; 78: 1506-1514. (Pubitemid 39552938)
17. Reese P, Tehrani T, Lim M, et al,. Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection. Clin J Am Soc Nephrol 2010; 5: 917-923.
18. Duan K, Englesbe M, Volk M,. Centers for disease control 'high-risk' donors and kidney utilization. Am J Transplant 2010; 10: 416-420.
19. Gordon E, Reddy E, Ladner D, Friedewald J, Ison M,. Transplant candidate perceptions of risk and specific informed consent for CDC-defined high risk donor organs. Abstract. In: American Transplant Congress. San Diego, CA, 2010.
20. Halpern SD, Shaked A, Hasz RD, Caplan AL,. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med 2008; 358: 2832-2837.
21. Gordon E, Reddy E, Ladner D, Friedewald J, Abecassis M, Ison M,. Kidney transplant candidates' understanding of increased risk donor kidneys: A qualitative study. Clin Transplant 2011, in press.
22. Rudow DL, Chariton M, Sanchez C, Chang S, Serur D, Brown RS, Jr,. Kidney and liver living donors: A comparison of experiences. Prog Transplant 2005; 15: 185-191.
23. Schover L, Streem S, Boparai N, Duriak K, Novick A,. The psychosocial impact of donating a kidney: Long-term followup from a urology based center. J Urol 1997; 157: 1596-1601. (Pubitemid 27171732)
24. Ross L., Good ethics requires good science: Why transplant programs should not disclose misattributed parentage. Am J Transplant 2010; 10: 742-746.
25. Finelli L, Miller J, Tokars J, Alter M, Arduino M,. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61. (Pubitemid 40348277)
26. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. Morb Mortal Wkly Rep 2001; 50 RR-5: 1-43.